Lipid unites disparate syndromes of sepsis
- 1 February 2004
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 10 (2) , 124-125
- https://doi.org/10.1038/nm0204-124
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Therapeutic effects of lysophosphatidylcholine in experimental sepsisNature Medicine, 2004
- Reversing established sepsis with antagonists of endogenous high-mobility group box 1Proceedings of the National Academy of Sciences, 2003
- Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patientsJournal of Lipid Research, 2003
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammationProceedings of the National Academy of Sciences, 2002
- HMGB1 as a Late Mediator of Lethal Systemic InflammationAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Lysophosphatidylcholine as a Ligand for the Immunoregulatory Receptor G2AScience, 2001
- Protection from septic shock by neutralization of macrophage migration inhibitory factorNature Medicine, 2000
- Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemiaNature, 1987
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986